Bandera Partners LLC purchased a new stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund purchased 61,000 shares of the company’s stock, valued at approximately $8,131,000. Molina Healthcare comprises 3.7% of Bandera Partners LLC’s investment portfolio, making the stock its 8th largest holding.
Other institutional investors have also recently added to or reduced their stakes in the company. Sei Investments Co. grew its stake in shares of Molina Healthcare by 24.5% in the 1st quarter. Sei Investments Co. now owns 67,024 shares of the company’s stock valued at $8,934,000 after purchasing an additional 13,204 shares during the last quarter. Cetera Investment Advisers raised its stake in shares of Molina Healthcare by 127.4% during the first quarter. Cetera Investment Advisers now owns 9,332 shares of the company’s stock worth $1,244,000 after purchasing an additional 5,229 shares during the last quarter. Kopernik Global Investors LLC raised its stake in shares of Molina Healthcare by 132.6% during the first quarter. Kopernik Global Investors LLC now owns 291,941 shares of the company’s stock worth $38,916,000 after purchasing an additional 166,407 shares during the last quarter. Alesco Advisors LLC An ESL Co purchased a new stake in shares of Molina Healthcare during the first quarter worth approximately $595,000. Finally, First Trust Advisors LP grew its position in Molina Healthcare by 5.8% in the 1st quarter. First Trust Advisors LP now owns 160,235 shares of the company’s stock valued at $21,359,000 after buying an additional 8,719 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.
Molina Healthcare Stock Performance
Shares of MOH opened at $200.30 on Friday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89. The company has a 50-day simple moving average of $205.93 and a 200-day simple moving average of $176.87. The company has a market capitalization of $10.44 billion, a PE ratio of -1,112.73 and a beta of 0.74.
Analysts Set New Price Targets
MOH has been the topic of several recent research reports. Truist Financial boosted their price objective on shares of Molina Healthcare from $205.00 to $250.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Morgan Stanley boosted their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Royal Bank Of Canada increased their price target on shares of Molina Healthcare from $216.00 to $248.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Sanford C. Bernstein set a $286.00 price objective on shares of Molina Healthcare in a research report on Monday, July 13th. Finally, Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a report on Wednesday, April 29th. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $207.06.
Check Out Our Latest Analysis on MOH
Molina Healthcare News Summary
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Molina reported Q2 EPS of $1.51, topping analyst estimates, and revenue of $10.87 billion also came in slightly above forecasts. The company also raised its full-year earnings outlook, helped by lower operating expenses and steadier Medicaid performance. Article Title
- Neutral Sentiment: Management highlighted stronger Medicaid execution in the earnings call, which supports the core business and may help offset pressure in other lines. Article Title
- Neutral Sentiment: Some investors were already cautious ahead of the report, with trading activity reflecting worries about guidance, cost trends, and tougher year-over-year comparisons. Article Title
- Negative Sentiment: The main concern is weaker premium revenue and declining membership, especially in Molina’s Obamacare/exchange business, which has led the company to expect a smaller presence in that segment. Article Title
- Negative Sentiment: Reports also pointed to lower net income, a higher medical care ratio, and a weak revenue outlook, suggesting margin pressure may continue even after the earnings beat. Article Title
Insider Buying and Selling
In related news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Recommended Stories
- Five stocks we like better than Molina Healthcare
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
